We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

114 hedge funds and large institutions have $734M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 39 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 13

18% more capital invested

Capital invested by funds: $620M → $734M (+$114M)

10% more funds holding

Funds holding: 104 → 114 (+10)

5% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 39

Holders
114
Holders Change
+10
Holders Change %
+9.62%
% of All Funds
3.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
37
Reduced
39
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RIM
Ranger Investment Management
Texas
+$15.9M
2
BFA
BlackRock Fund Advisors
California
+$7.18M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.27M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.76M
5
TCM
Timpani Capital Management
Wisconsin
+$3.63M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$17.1M
2
BC
Broadfin Capital
New York
-$8.54M
3
NIMC
NWQ Investment Management Company
California
-$7.71M
4
Millennium Management
Millennium Management
New York
-$5.39M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$5.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
26
Principal Financial Group
Iowa
$4.48M +$173K +6,390 +5%
TC
27
TFS Capital
Pennsylvania
$4.37M +$3.03M +111,996 +393%
TCM
28
Timpani Capital Management
Wisconsin
$4.16M +$3.63M +133,875 New
Geode Capital Management
29
Geode Capital Management
Massachusetts
$3.81M +$50.3K +1,857 +2%
Ameriprise
30
Ameriprise
Minnesota
$3.07M +$2.67M +98,670 New
TCIM
31
TIAA CREF Investment Management
New York
$2.96M -$87.1K -3,217 -3%
Prudential Financial
32
Prudential Financial
New Jersey
$2.68M +$1.11M +40,806 +90%
Invesco
33
Invesco
Georgia
$2.4M +$71.7K +2,648 +4%
SIM
34
Spark Investment Management
New York
$2.4M +$1.06M +39,000 +102%
Deutsche Bank
35
Deutsche Bank
Germany
$2.39M +$308K +11,388 +17%
CCM
36
Cadence Capital Management
Massachusetts
$2.33M -$2.84M -104,840 -58%
BIM
37
BlackRock Investment Management
Delaware
$2.33M +$50.8K +1,877 +3%
Canada Life
38
Canada Life
Manitoba, Canada
$2.25M +$88.2K +3,255 +5%
OAM
39
Oxford Asset Management
United Kingdom
$2.2M -$387K -14,285 -17%
FLAM
40
First Light Asset Management
Minnesota
$2.19M +$51.1K +1,888 +3%
Ohio Public Employees Retirement System (OPERS)
41
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.1M – – –
CCMH
42
Cornerstone Capital Management Holdings
New York
$1.91M -$1.62M -59,900 -49%
BIM
43
Bogle Investment Management
Massachusetts
$1.82M +$1.58M +58,495 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$1.64M +$1.43M +52,800 New
QBFM
45
QS Batterymarch Financial Management
New York
$1.48M -$73.1K -2,700 -5%
Public Sector Pension Investment Board (PSP Investments)
46
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.32M -$119K -4,400 -9%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.25M +$11.6K +429 +1%
GT
48
Glenmede Trust
Pennsylvania
$1.11M – – –
AllianceBernstein
49
AllianceBernstein
Tennessee
$1.08M +$103K +3,800 +12%
EI
50
EAM Investors
California
$1.08M +$941K +34,729 New
1
2
3 4 5

SGNT Hedge Fund Activity: Q3 2014 in Review

114 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q3 2014, worth a combined $734M — up 18% from $620M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new SGNT positions and 13 closed out — a net gain of 10 holders — while 37 added to existing stakes and 39 trimmed.

The largest buyer was Ranger Investment Management, opening a new position worth an estimated $15.9M. The largest seller was Franklin Resources, cutting an estimated $17.1M.

  • 114 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q3 2014, up from 104 in Q2 2014.
  • Funds reported $734M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q3 2014, up 18% quarter-over-quarter.
  • 23 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q3 2014 and 13 closed out, a net change of +10 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2014 was Ranger Investment Management, an estimated $15.9M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q3 2014 was Franklin Resources, an estimated $17.1M sold.

Based on aggregated 13F filings for Q3 2014.